Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.
Exome-wide somatic mutation characterization of small bowel adenocarcinoma.
Plos Genetics
Hänninen, Ulrika A UA; Katainen, Riku R; Tanskanen, Tomas T; Plaketti, Roosa-Maria RM; Laine, Riku R; Hamberg, Jiri J; Ristimäki, Ari A; Pukkala, Eero E; Taipale, Minna M; Mecklin, Jukka-Pekka JP; Forsström, Linda M LM; Pitkänen, Esa E; Palin, Kimmo K; Välimäki, Niko N; Mäkinen, Netta N; Aaltonen, Lauri A LA
Epidermal growth factor receptor (EGFR) polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.
International Journal Of Molecular Epidemiology And Genetics
Connor, Avonne E AE; Baumgartner, Richard N RN; Baumgartner, Kathy B KB; Pinkston, Christina M CM; John, Esther M EM; Torres-Mejía, Gabriela G; Hines, Lisa M LM; Giuliano, Anna R AR; Wolff, Roger K RK; Slattery, Martha L ML
Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets.
Bioinformatics And Biology Insights
Isokpehi, Raphael D RD; Cohly, Hari H P HH; Anyanwu, Matthew N MN; Rajnarayanan, Rajendram V RV; Tchounwou, Paul B PB; Udensi, Udensi K UK; Graham-Evans, Barbara E BE